Cuu Long Pharmaceutical JSC
VN:DCL
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22 350
30 400
|
Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DCL stock under the Base Case scenario is 24 894.23 VND. Compared to the current market price of 26 800 VND, Cuu Long Pharmaceutical JSC is Overvalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cuu Long Pharmaceutical JSC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DCL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cuu Long Pharmaceutical JSC
Balance Sheet Decomposition
Cuu Long Pharmaceutical JSC
Current Assets | 1.5T |
Cash & Short-Term Investments | 221.9B |
Receivables | 788.6B |
Other Current Assets | 503.3B |
Non-Current Assets | 900.1B |
PP&E | 860.4B |
Intangibles | 23.2B |
Other Non-Current Assets | 16.5B |
Current Liabilities | 679.2B |
Accounts Payable | 124B |
Accrued Liabilities | 32.7B |
Short-Term Debt | 373.1B |
Other Current Liabilities | 149.4B |
Non-Current Liabilities | 273B |
Long-Term Debt | 254.5B |
Other Non-Current Liabilities | 18.6B |
Earnings Waterfall
Cuu Long Pharmaceutical JSC
Revenue
|
1.2T
VND
|
Cost of Revenue
|
-962.9B
VND
|
Gross Profit
|
222.3B
VND
|
Operating Expenses
|
-127.9B
VND
|
Operating Income
|
94.3B
VND
|
Other Expenses
|
-25.1B
VND
|
Net Income
|
69.3B
VND
|
Free Cash Flow Analysis
Cuu Long Pharmaceutical JSC
VND | |
Free Cash Flow | VND |
DCL Profitability Score
Profitability Due Diligence
Cuu Long Pharmaceutical JSC's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Cuu Long Pharmaceutical JSC's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
DCL Solvency Score
Solvency Due Diligence
Cuu Long Pharmaceutical JSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Cuu Long Pharmaceutical JSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DCL Price Targets Summary
Cuu Long Pharmaceutical JSC
Dividends
Current shareholder yield for DCL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cuu Long Pharmaceutical JSC engages in the manufacture, sale, import, and export of pharmaceutical, capsules, and medical instruments. The company is headquartered in Vinh Long, Vinh Long and currently employs 934 full-time employees. The company went IPO on 2008-09-17. The firm manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. The company is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
Contact
IPO
Employees
Officers
The intrinsic value of one DCL stock under the Base Case scenario is 24 894.23 VND.
Compared to the current market price of 26 800 VND, Cuu Long Pharmaceutical JSC is Overvalued by 7%.